Directed share issue in Vicore Pharma Holding AB (SE) — SEK 500 million Healthcare Directed share issue in Vicore Pharma Holding AB (SE) — SEK 500 million
Rights issue in Q-linea AB (SE) — SEK 263 million Healthcare Rights issue in Q-linea AB (SE) — SEK 263 million
Recommended public offer to the shareholders and warrant holders of Sensidose AB (SE) by Navamedic ASA (NO) – SEK 103 million Healthcare Recommended public offer to the shareholders and warrant holders of Sensidose AB (SE) by Navamedic ASA (NO) – SEK 103 million
Rights issue in Infant Bacterial Therapeutics AB (SE) — SEK 100 million Healthcare Rights issue in Infant Bacterial Therapeutics AB (SE) — SEK 100 million
Private placement in Mathem (SE) – SEK 1.0 billion Consumer & Retail Private placement in Mathem (SE) – SEK 1.0 billion
Rights issue in VNV Global AB (SE) — SEK 328 million FIG Rights issue in VNV Global AB (SE) — SEK 328 million
Senior unsecured dark green bond issue by AB Stena Metall (SE) – SEK 1,000 million Cleantech, Renewables & Infrastructure Senior unsecured dark green bond issue by AB Stena Metall (SE) – SEK 1,000 million
Debt financing for Occlutech Holding AG (CH) – EUR 40 million Healthcare Debt financing for Occlutech Holding AG (CH) – EUR 40 million
Private placement in Xshore AB (SE) — SEK 300 million Cleantech, Renewables & Infrastructure Private placement in Xshore AB (SE) — SEK 300 million
Capital increase in NA-KD (SE) — EUR 20 million Consumer & Retail Capital increase in NA-KD (SE) — EUR 20 million
Senior unsecured green bond issue by NP3 Fastigheter AB (SE) – SEK 500 million Real Estate Senior unsecured green bond issue by NP3 Fastigheter AB (SE) – SEK 500 million